Ragnhild Wergeland
Position:
Phone:
Email:
 

Author network for Ragnhild Wergeland by COREMINE medical


Publications 2012

Askevold ET, Nymo S, Ueland T, Gravning J, Wergeland R, Kjekshus J, Yndestad A, Cleland JG, McMurray JJ, Aukrust P, Gullestad L (2012)
Soluble glycoprotein 130 predicts fatal outcomes in chronic heart failure: analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
Circ Heart Fail, 6 (1), 91-8
PubMed 23230311

Broch K, Eek C, Wergeland R, Ueland T, Skårdal R, Aukrust P, Skulstad H, Gullestad L (2012)
NT-proBNP predicts myocardial recovery after non-ST-elevation acute coronary syndrome
Scand Cardiovasc J, 46 (2), 65-71
PubMed 22191851

Solberg OG, Ueland T, Wergeland R, Dahl CP, Aakhus S, Aukrust P, Gullestad L (2012)
High-sensitive troponin T and N-terminal-brain-natriuretic-peptide predict outcome in symptomatic aortic stenosis
Scand Cardiovasc J, 46 (5), 278-85
PubMed 22545649

Publications 2011

Aarones M, Gullestad L, Aakhus S, Ueland T, Skaardal R, Aass H, Wergeland R, Smith HJ, Aukrust P, Kongsgaard E (2011)
Prognostic value of cardiac troponin T in patients with moderate to severe heart failure scheduled for cardiac resynchronization therapy
Am Heart J, 161 (6), 1031-7
PubMed 21641347

Publications 2010

Aarønæs M, Aakhus S, Aass H, Moum T, Wergeland R, Gullestad L, Kongsgård E (2010)
Assessment of response criteria to cardiac resynchronization therapy (CRT) and prediction of response
Scand Cardiovasc J, 44 (6), 337-45
PubMed 21080864

Publications 2009

Arora S, Aukrust P, Ueland T, Broch K, Simonsen S, Gude E, Fiane AE, Geiran O, Wergeland R, Andreassen AK, Gullestad L (2009)
Elevated serum uric acid levels following heart transplantation predict all-cause and cardiac mortality
Eur J Heart Fail, 11 (10), 1005-13
PubMed 19737803

Publications 2007

Arora S, Gullestad L, Wergeland R, Simonsen S, Holm T, Hognestad A, Ueland T, Geiran O, Andreassen A (2007)
Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation
Transplantation, 83 (10), 1308-15
PubMed 17519779

Johansen OE, Birkeland KI, Orvik E, Flesland Ø, Wergeland R, Ueland T, Smith C, Endresen K, Aukrust P, Gullestad L (2007)
Inflammation and coronary angiography in asymptomatic type 2 diabetic subjects
Scand J Clin Lab Invest, 67 (3), 306-16
PubMed 17454845

Omland T, Sabatine MS, Jablonski KA, Rice MM, Hsia J, Wergeland R, Landaas S, Rouleau JL, Domanski MJ, Hall C, Pfeffer MA, Braunwald E, PEACE Investigators (2007)
Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial
J Am Coll Cardiol, 50 (3), 205-14
PubMed 17631211

Wethal T, Kjekshus J, Røislien J, Ueland T, Andreassen AK, Wergeland R, Aukrust P, Fosså SD (2007)
Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer
J Cancer Surviv, 1 (1), 8-16
PubMed 18648940

Publications 2006

Andreassen AK, Wergeland R, Simonsen S, Geiran O, Guevara C, Ueland T (2006)
N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension
Am J Cardiol, 98 (4), 525-9
PubMed 16893710

Bollerslev J, Ueland T, Jørgensen AP, Fougner KJ, Wergeland R, Schreiner T, Burman P (2006)
Positive effects of a physiological dose of GH on markers of atherogenesis: a placebo-controlled study in patients with adult-onset GH deficiency
Eur J Endocrinol, 154 (4), 537-43
PubMed 16556716

Heringlake M, Will B, Klaus S, Heinze H, Wagner K, Pagel H, Wergeland R, Bahlmann L (2006)
The effects of angiotensin-converting enzyme inhibition on the urinary excretion of NTproBNP in male volunteers
Kidney Blood Press Res, 29 (5), 294-305
PubMed 17057415

Holm T, Ueland T, Halvorsen B, Hognestad A, Holm AG, Wergeland R, Gullestad L, Aukrust P, Kjekshus J (2006)
A protective anti-inflammatory phenotype in high-risk individuals who do not develop coronary artery disease
J Am Coll Cardiol, 47 (5), 1085-6
PubMed 16516099

Kurz K, Voelker R, Zdunek D, Wergeland R, Hess G, Ivandic B, Katus H, Giannitsis E (2006)
Effect of stress-induced reversible ischemia on serum concentrations of ischemia-modified albumin, natriuretic peptides and placental growth factor
Clin Res Cardiol, 96 (3), 152-9
PubMed 17180576

Olsen MH, Wachtell K, Nielsen OW, Hall C, Wergeland R, Ibsen H, Kjeldsen SE, Devereux RB, Dahlöf B, Hildebrandt PR (2006)
N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy
J Hypertens, 24 (8), 1531-9
PubMed 16877955

Publications 2005

Fiane AE, Ueland T, Simonsen S, Scott H, Endresen K, Gullestad L, Geiran OR, Haraldsen G, Heggelund L, Andreassen AK, Wergeland R, Frøland S, Aukrust P, Mollnes TE (2005)
Low mannose-binding lectin and increased complement activation correlate to allograft vasculopathy, ischaemia, and rejection after human heart transplantation
Eur Heart J, 26 (16), 1660-5
PubMed 15821010

Gullestad L, Ueland T, Fjeld JG, Holt E, Gundersen T, Breivik K, Følling M, Hodt A, Skårdal R, Kjekshus J, Andreassen A, Kjekshus E, Wergeland R, Yndestad A, Frøland SS, Semb AG, Aukrust P (2005)
Effect of thalidomide on cardiac remodeling in chronic heart failure: results of a double-blind, placebo-controlled study
Circulation, 112 (22), 3408-14
PubMed 16301340

Hognestad A, Endresen K, Wergeland R, Mellembakken JR, Mollnes TE, Omland T, Kjekshus JK, Aukrust P, Andreassen AK (2005)
Inflammatory response and re-stenosis after percutaneous coronary intervention in heart transplant recipients and patients with native atherosclerosis
J Heart Lung Transplant, 24 (8), 1026-32
PubMed 16102437

Michelsen AE, Wergeland R, Stokke O, Brosstad F (2005)
Development of a time-resolved immunofluorometric assay for quantifying platelet-derived microparticles in human plasma
Thromb Res, 117 (6), 705-11
PubMed 15990159

Omland T, Richards AM, Wergeland R, Vik-Mo H (2005)
B-type natriuretic peptide and long-term survival in patients with stable coronary artery disease
Am J Cardiol, 95 (1), 24-8
PubMed 15619389

Publications 2004

Heringlake M, Heide C, Bahlmann L, Eichler W, Pagel H, Schmucker P, Wergeland R, Armbruster FP, Klaus S (2004)
Effects of tilting and volume loading on plasma levels and urinary excretion of relaxin, NT-pro-ANP, and NT-pro-BNP in male volunteers
J Appl Physiol (1985), 97 (1), 173-9
PubMed 14990550

Hognestad A, Aukrust P, Wergeland R, Stokke O, Gullestad L, Semb AG, Holm T, Andreassen AK, Kjekshus JK (2004)
Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation
Clin Cardiol, 27 (4), 199-203
PubMed 15119693

Publications 2003

Hognestad A, Endresen K, Wergeland R, Stokke O, Geiran O, Holm T, Simonsen S, Kjekshus JK, Andreassen AK (2003)
Plasma C-reactive protein as a marker of cardiac allograft vasculopathy in heart transplant recipients
J Am Coll Cardiol, 42 (3), 477-82
PubMed 12906976

Publications 2002

Djurovic S, Clausen T, Wergeland R, Brosstad F, Berg K, Henriksen T (2002)
Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia
BJOG, 109 (7), 759-64
PubMed 12135211

Djurovic S, Clausen T, Wergeland R, Brosstad F, Berg K, Henriksen T (2002)
Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia
BJOG, 109 (7), PII S1470-0328(02)01330-7-764

Publications 2001

Oyen O, Wergeland R, Bentdal O, Hartmann A, Brekke IB, Stokke O (2001)
Serial ultrasensitive CRP measurements may be useful in rejection diagnosis after kidney transplantation
Transplant Proc, 33 (4), 2481-3
PubMed 11406220

Publications 1999

Wergeland R, Oyen O, Bentdal O, Stokke O (1999)
MicroCRP: a highly sensitive CRP method applied in the monitoring of renal allograft recipients
Scand J Clin Lab Invest, 59 (6), 405-16
PubMed 10612551

Publications 1996

Thoresen SI, Wergeland R, Mørkrid L, Stokke O (1996)
Evaluation of an enzymatic immunoassay for free thyroxine determination in canine serum
Vet Res Commun, 20 (5), 411-20
PubMed 8908721

Publications 1995

Bjøro T, Mørkrid L, Wergeland R, Turter A, Kvistborg A, Sand T, Torjesen P (1995)
Frequency of hyperprolactinaemia due to large molecular weight prolactin (150-170 kD PRL)
Scand J Clin Lab Invest, 55 (2), 139-47
PubMed 7667607

Publications 1993

WERGELAND R, MORKRID L, ABYHOLM T (1993)
EVALUATION OF THE ABBOTT IMX ESTRADIOL ASSAY
J. Clin. Immunoass., 16 (3), 238-243

Publications 1986

STOKKE KT, ROOTWELT K, WERGELAND R, VALE JR (1986)
CHANGES IN PLASMA AND RED-CELL VOLUMES DURING EXPOSURE TO HIGH-ALTITUDE
Scand. J. Clin. Lab. Invest., 46 184, 113-117

Stokke KT, Rootwelt K, Wergeland R, Vale JR (1986)
Changes in plasma and red cell volumes during exposure to high altitude
Scand J Clin Lab Invest Suppl, 184, 113-7
PubMed 3473608

Taubøll E, Gjerstad L, Stokke KT, Wergeland R (1986)
No monthly variations in serum levels of thyroid hormones in human males
Horm Metab Res, 18 (7), 500-1
PubMed 3744295

Publications 1984

Opstad PK, Falch D, Oktedalen O, Fonnum F, Wergeland R (1984)
The thyroid function in young men during prolonged exercise and the effect of energy and sleep deprivation
Clin Endocrinol (Oxf), 20 (6), 657-69
PubMed 6432374

Rootwelt K, Wergeland R, Lie SO, Natvig K (1984)
[Thyroglobulin in serum. A useful diagnostic test in cancer of the thyroid, thyrotoxicosis factitia, athyreosis/ectopy and hereditary dyshormonogenesis]
Tidsskr Nor Laegeforen, 104 (4), 231-5
PubMed 6701866